Clinical Trials Update: Jan. 3, 2008
1816
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
121268
EPIX initiates a safety trial and gets good efficacy data.
535175
BioSante releases more info on the pivotal studies for its lead drug.
383605
China&#39;s SARS vaccine trials are expected to be completed by January as clinical experiments are going smoothly, state media reports.
583563
a widely prescribed arthritis treatment - more than doubled patients&#39; risk of heart problems in a clinical study. The announcement, 11 weeks after Merck &amp; Co.
306233
THURSDAY, July 5 (HealthDay News) -- New research suggests that the timing of when a woman receives the breast cancer drug Herceptin can influence its effect on her heart.
93775
Encouraging phase II results of a trial to test the efficacy of a malaria vaccine for young children is published in this week&#39;s issue of THE LANCET (pp 1380, 1411).
589264
Panacos releases more clinical trial results for an exciting drug.
335462
Description: A consortium of leading medical journals wants to prevent publication of clinical trial results that overemphasize positive data.
704575
NEW YORK -- A new study has linked painkillers Vioxx, Celebrex, and Bextra to increased cardiovascular risk, reinforcing findings of other trials that have already sparked concern over the safety of a popular category of drugs.
62269
A New Jersey court awards damages to Idaho couple in Vioxx case.Plus: SEC and OSC file complaints against former Nortel execs... Bush administration says it's fish farming season... and more.
621066
Two newly published studies in the September 17, 2004 issue of Science give rise to the possibility of developing drug therapies that target eosinophils, white blood cells long known to be associated with the asthma.
25501
(December 29, 2004) - Six clinical studies at the University of Rochester Medical Center have ended because of findings that question the safety of the drugs under investigation.
122956
Many clinical cancer trials are not published in order to keep industry secrets. A British cancer research group calls for all studies to be published -- even those with marginal results -- so doctors are not misled.
414190
FRANKFURT/CHICAGO  - U.S. regulators have demanded  more clinical studies of a new substance designed to produce  clearer MRI pictures of clogged arteries, Germany's Schering AG  and U.S. partner Epix Pharmaceuticals Inc. said on Friday.
310131
Aventis, part of the sanofi-aventis Group (EURONEXT: SAN), announced today that The New England Journal of Medicine has published the results of two landmark phase III studies, which demonstrate that Taxotere (docetaxel) Injection Concentrate-based
501444
The Food and Drug Administration has approved a new drug for multiple sclerosis that in clinical trials got better results than existing drugs in protecting against relapses.